Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Patrolling Monocytes Scavenge Endothelial Adherent Sickle Red Blood Cells in Sickle Cell Disease

Yunfeng Liu, PhD, Hui Zhong, PhD, Weili Bao, MS, Avital Mendelson, PhD, Xiuli An, MD PhD, Patricia Shi, MD, Stella T. Chou, MD, Deepa Manwani, MD, Karina Yazdanbakhsh, PhD

Blood (2018) 132 (Supplement 1): 744.

https://doi.org/10.1182/blood-2018-99-118527

Published: 2018

Journal Articles

Accurate Prediction of RH Genotypes Using Whole Genome Sequencing Data

Yan Zheng, MD PhD, Ti-Cheng Chang, PhD, Gang Wu, PhD, Jane S. Hankins, MD MS, Mitchell J. Weiss, MD PhD, Connie M. Westhoff, PhD, Stella T. Chou, MD

Blood (2018) 132 (Supplement 1): 2332.

https://doi.org/10.1182/blood-2018-99-119681

Published: 2018

Journal Articles

Protective Role of HO-1 Expressing CD16+ Patrolling Monocytes Against Hemolysis-Induced Endothelial Damage and Vaso-Occlusive Crisis in Sickle Cell Disease

Yunfeng Liu, PhD, Fangmiao Jing, Woelsung Yi, PhD, Avital Mendelson, PhD, Patricia Shi, MD, Ronald Walsh, MD, David F. Friedman, MD, Caterina Minniti, MD, Deepa Manwani, MD, Stella T Chou, MD, Karina Yazdanbakhsh, PhD

Blood (2017) 130 (Supplement 1): 767.

https://doi.org/10.1182/blood.V130.Suppl_1.767.767

Published: 2017

Journal Articles

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

David Posocco, Hyun H An, Jean Ann Maguire, Judith Aeschlimann, Deborah L French, PhD, Paul Gadue, PhD, Connie M. Westhoff, PhD, Stella T Chou, MD

Blood (2017) 130 (Supplement 1): 3.

https://doi.org/10.1182/blood.V130.Suppl_1.3.3

Published: 2017

Journal Articles

Mutation-Specific Signaling Profiles and Therapeutic Vulnerabilities of Induced Pluripotent Stem Cell Models of Juvenile Myelomonocytic Leukemia

Sarah K Tasian, MD, Jessica A Casas, MD MPH, David Posocco, Shilpa Gandre-Babbe, Alyssa Gagne, Ge Liang, Mignon L. Loh, MD, Mitchell J Weiss, MD PhD, Deborah L French, PhD, Stella T Chou, MD

Blood (2017) 130 (Supplement 1): 1678.

https://doi.org/10.1182/blood.V130.Suppl_1.1678.1678

Published: 2017

Journal Articles

Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells

Jeremy D. Grevet, Nicole Hamagami, Xianjiang Lan, PhD, Laavanya Sankaranarayanan, MS, Saurabh Bhardwaj, PhD, Carolyne Face, David Posocco, Osheiza Abdulmalik, DVM, Cheryl A. Keller, PhD, Belinda Giardine, Simone Sidoli, PhD, Ben Garcia, PhD, Stella T Chou, MD, Ross C Hardison, PhD, Chris Vakoc, MD PhD, Junwei Shi, PhD, Gerd A. Blobel, MD PhD

Blood (2017) 130 (Supplement 1): 536.

https://doi.org/10.1182/blood.V130.Suppl_1.536.536

Published: 2017

Journal Articles

Altered Heme-Mediated Modulation of Dendritic Cell Function in Sickle Cell Alloimmunization

Emmanuelle Godefroy, PhD, Yunfeng Liu, PhD, Patricia A Shi, MD, W. Beau Mitchell, MD, Devin Cohen, BSc, Stella T. Chou, MD, Deepa Manwani, MD, Karina Yazdanbakhsh, PhD

Blood (2015) 126 (23): 655.

https://doi.org/10.1182/blood.V126.23.655.655

Published: 2015

Journal Articles

Feasibility of RH Genetic Matching for Patients with Sickle Cell Disease with an African-American Donor Pool

Stella T. Chou, MD, David F. Friedman, MD, Tannoa Jackson, BS, Sunitha Vege, Margaret A. Keller, PhD, Connie M Westhoff, PhD

Blood (2014) 124 (21): 2893.

https://doi.org/10.1182/blood.V124.21.2893.2893

Published: 2014

Journal Articles

Inducible Gata1 Suppression As a Novel Strategy to Expand Physiologic Megakaryocyte Production from Embryonic Stem Cells

Ji-Yoon Noh, PhD, Shilpa Gandre-Babbe, PhD, Yuhuan Wang, PhD, Vincent Hayes, BS, Yu Yao, Paul Gadue, PhD, Spencer Sullivan, MD, Stella T. Chou, MD, Vikram R Paralkar, MD, Kellie R Machlus, PhD, Joseph E. Italiano, PhD, Michael Kyba, PhD, Deborah L. French, PhD, Mortimer Poncz, MD, Mitchell J. Weiss, MD PhD

Blood (2014) 124 (21): 3846.

https://doi.org/10.1182/blood.V124.21.3846.3846

Published: 2014

Journal Articles

Insights Into Thrombopoiesis From Infused Human Megakaryocytes Into Mice

Yuhuan Wang, PhD, Vincent M. Hayes, Prasuna Paluru, Stella T. Chou, MD, Deborah L. French, Mortimer Poncz, MD

Blood (2013) 122 (21): 1165.

https://doi.org/10.1182/blood.V122.21.1165.1165

Published: 2013

Journal Articles

Variant RH in Patients with Sickle Cell Disease Is Associated with Clinically Significant Alloimmunization

Stella T Chou, MD, Tannoa Jackson, Sunitha Vege, David Friedman, MD, Connie M Westhoff, PhD

Blood (2012) 120 (21): 3239.

https://doi.org/10.1182/blood.V120.21.3239.3239

Published: 2012

Journal Articles

Aryl Hydrocarbon Receptor (AhR) Antagonist Stemregenin 1 (SR1) Enhances in Vitro- and in Vivo-Derived Platelets (PLTs) From Human Megakaryocytes (MKs)

Yuhuan Wang, PhD, Vincent M. Hayes, Lin Lu, Ph.D, Xiaoji Chen, Rudy Fuentes, PhD, Qiang Jeremy Wen, MD, PhD, Stella T Chou, MD, John Crispino, PhD, Patrick Paddison, PhD, Deborah L. French, PhD, Beverly Torok-Storb, PhD, Mortimer Poncz, MD

Blood (2012) 120 (21): 3450.

https://doi.org/10.1182/blood.V120.21.3450.3450

Published: 2012

Journal Articles

Donor Availability for Extended Phenotype Matching for Transfusion in Thalassemia and Sickle Cell Disease.

Connie M Westhoff, PhD, Marek Simm, MT, Carl Myers, Stella T Chou, MD, Adonis Stassinopoulos, PhD, Beth H Shaz, MD

Blood (2012) 120 (21): 2287.

https://doi.org/10.1182/blood.V120.21.2287.2287

Published: 2012

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Recapitulate Hematopoietic Abnormalities of Juvenile Myelomonocytic Leukemia

Gandre-Babbe Shilpa, PhD, Stella T Chou, MD, Deborah L. French, PhD, Michelle Kang, Julie Weng, Helene Favre, Mignon L Loh, MD, Mitchell J Weiss, MD

Blood (2011) 118 (21): 637.

https://doi.org/10.1182/blood.V118.21.637.637

Published: 2011

Journal Articles

Use of Genomics for Transfusion Therapy Management in Patients with Sickle Cell Disease

Connie M Westhoff, PhD, Stella T Chou, MD, Kim Smith-Whitley, MD, David Friedman, MD

Blood (2011) 118 (21): 2324.

https://doi.org/10.1182/blood.V118.21.2324.2324

Published: 2011

Journal Articles

Development of Acute Megakaryoblastic Leukemia in Down Syndrome Is Associated with Sequential Epigenetic Changes That Target the Down Syndrome Critical Region on Chromosome 21,

Maria E Figueroa, MD, Sebastien Malinge, PhD, Timothy M Chlon, Yushan Li, Elisabeth Paietta, PhD, Hugo F. Fernandez, MD, Martin S. Tallman, MD, Mitchell J Weiss, MD, Stella T Chou, MD, Ari Melnick, MD, John Crispino, PhD

Blood (2011) 118 (21): 3451.

https://doi.org/10.1182/blood.V118.21.3451.3451

Published: 2011

Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Reveal Distinct Hematopoietic Defects Conferred by Trisomy 21 and Truncated GATA-1

Stella T Chou, MD, Daniel VanDorn, Yu Yao, Deborah L. French, PhD, Mitchell J Weiss, MD

Blood (2011) 118 (21): 911.

https://doi.org/10.1182/blood.V118.21.911.911

Published: 2011

Journal Articles

Comparison of RH Genotypes In Rh Alloimmunized and Non-Alloimmunized Patients with Sickle Cell Disease.

Stella T Chou, MD, David Friedman, MD, Tannoa Jackson, Kim Smith-Whitley, MD, Connie M Westhoff

Blood (2010) 116 (21): 1122.

https://doi.org/10.1182/blood.V116.21.1122.1122

Published: 2010

Journal Articles

Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL

Sebastien Malinge, PhD, Gina Kirsammer, PhD, Meghan Bliss-Moreau, Timothy M Chlon, Lauren Diebold, Stella T Chou, MD, Mitchell Weiss, MD, Sandeep Gurbuxani, MBBS, PhD, John Crispino, PhD

Blood (2010) 116 (21): 469.

https://doi.org/10.1182/blood.V116.21.469.469

Published: 2010

Journal Articles

Graded Repression of PU.1 Expression by GATA Factors Influence Hematopoietic Progenitor Cell Fate

Stella T. Chou, MD, Charles Bailey, M.D., Yu Yao, Zan Huang, PhD, Kim Nichols, MD, John Crispino, PhD, Ross Hardison, Ph.D., Gerd Blobel, MD, PhD, Chris Vakoc, MD, PhD, Mitchell J. Weiss, M.D., Ph.D.

Blood (2008) 112 (11): 2469.

https://doi.org/10.1182/blood.V112.11.2469.2469

Published: 2008

NARROW

Patrolling Monocytes Scavenge Endothelial Adherent Sickle Red Blood Cells in Sickle Cell Disease

Accurate Prediction of RH Genotypes Using Whole Genome Sequencing Data

Protective Role of HO-1 Expressing CD16+ Patrolling Monocytes Against Hemolysis-Induced Endothelial Damage and Vaso-Occlusive Crisis in Sickle Cell Disease

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

Mutation-Specific Signaling Profiles and Therapeutic Vulnerabilities of Induced Pluripotent Stem Cell Models of Juvenile Myelomonocytic Leukemia

Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells

Altered Heme-Mediated Modulation of Dendritic Cell Function in Sickle Cell Alloimmunization

Feasibility of RH Genetic Matching for Patients with Sickle Cell Disease with an African-American Donor Pool

Inducible Gata1 Suppression As a Novel Strategy to Expand Physiologic Megakaryocyte Production from Embryonic Stem Cells

Insights Into Thrombopoiesis From Infused Human Megakaryocytes Into Mice

Variant RH in Patients with Sickle Cell Disease Is Associated with Clinically Significant Alloimmunization

Aryl Hydrocarbon Receptor (AhR) Antagonist Stemregenin 1 (SR1) Enhances in Vitro- and in Vivo-Derived Platelets (PLTs) From Human Megakaryocytes (MKs)

Donor Availability for Extended Phenotype Matching for Transfusion in Thalassemia and Sickle Cell Disease.

Patient-Derived Induced Pluripotent Stem Cells Recapitulate Hematopoietic Abnormalities of Juvenile Myelomonocytic Leukemia

Use of Genomics for Transfusion Therapy Management in Patients with Sickle Cell Disease

Development of Acute Megakaryoblastic Leukemia in Down Syndrome Is Associated with Sequential Epigenetic Changes That Target the Down Syndrome Critical Region on Chromosome 21,

Patient-Derived Induced Pluripotent Stem Cells Reveal Distinct Hematopoietic Defects Conferred by Trisomy 21 and Truncated GATA-1

Comparison of RH Genotypes In Rh Alloimmunized and Non-Alloimmunized Patients with Sickle Cell Disease.

Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL

Graded Repression of PU.1 Expression by GATA Factors Influence Hematopoietic Progenitor Cell Fate

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only